Global assessment and itch/scratch scores highlight the effectiveness of topical roflumilast for treating atopic dermatitis in children 3 months to 2 years old, in a phase 2 study.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/roflumilast-shows-promise-treating-atopic-dermatitis-2026a10009ia?src=rss
Author :
Publish date : 2026-03-28 16:34:00
Copyright for syndicated content belongs to the linked Source.
